Skip to main content

Part of the book series: Current Clinical Practice ((CCP))

  • 271 Accesses

Abstract

Alpha-1-antitrypsin (α1AT) is a protease inhibitor, the deficiency of which is associated with premature emphysema and a wide spectrum of liver disease. This protein is a small glycoprotein that migrates electrophoretically with the α1-globulin fraction of serum. Alpha-1-antitrypsin is a protein coded for by a gene, referred to as PI, located on the long arm of chromosome 14. That certain forms of premature emphysema had an inherited basis was first postulated by Laurell, Eriksson, and Axelsson in 1965 (1). Electrophoretic variants of α1AT were described throughout the 1960s. The first description of infantile liver cirrhosis in a homozygote for α1AT deficiency was made by Gans et al. in 1969 (2). Neonatal cholestasis associated with alpha-1-antitrypsin deficiency was described in 1972 (3).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Eriksson S. Studies in alpha-1-antitrypsin deficiency. Acta Med Scand Suppl 1965;432:1–85.

    PubMed  CAS  Google Scholar 

  2. Gans H, Sharp HL, Tan BH. Antiprotease deficiency and familial infantile liver cirrhosis. Surg Gynec Obstet 1969;129:289–299.

    PubMed  CAS  Google Scholar 

  3. Aagenaes O, Matlary A, Elgjo K, Munthe E, Fagerhol M. Neonatal cholestasis in alpha-1-antitrypsin deficient children: clinical, genetic, histological and immunohistochemical findings. Acta Paediat Scand 1992;61:632–642.

    Google Scholar 

  4. Stevens PM, Hnilica V, Johnson PC, Bell RL. Pathophysiology of hereditary emphysema. Ann Intern Med 1971;74:672–680.

    PubMed  CAS  Google Scholar 

  5. Kennedy M, Brett W. Monozygotic twins with alpha-1-antitrypsin deficiency (Letter). Lancet 1985;1(8427):527–528.

    Article  PubMed  CAS  Google Scholar 

  6. Nukiwa T, Satoh K, Brantly M L, et al. Identification of a second mutation in the protein-coding sequence of the Z type alpha-1-antitrypsin gene. J Biol Chem 1986;261:15, 989-15,994.

    Google Scholar 

  7. Cox DW, Woo SLC, Mansfield T. DNA restriction fragments associated with alpha-1-antitrypsin indicate a single origin for deficiency allele PI Z. Nature 1985;316:79–88.

    Article  PubMed  CAS  Google Scholar 

  8. Roychoudhury AK, Nei M. Human polymorphic genes: world distribution. Oxford Univ Press, New York, 1988, pp. 132–135.

    Google Scholar 

  9. Cox DW. Alpha-1-antitrypsin deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease, 6th ed. McGraw-Hill, New York, 1989, pp. 2409–2437.

    Google Scholar 

  10. Crystal RG. The alpha-1-antitrypsin gene and its deficiency states. Trends Genet 1989;5:411–417.

    Article  PubMed  CAS  Google Scholar 

  11. Cox DW, Smyth S. Risk for liver disease in adults with alpha 1-antitrypsin deficiency. Am J Med 1983;74:221–227.

    Article  PubMed  CAS  Google Scholar 

  12. Wu Y, Whitman I, Molmenti E, Moore K, Hippenmeyer P, Perlmutter DH. A lag in intracellular degradation of mutant alpha-1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ alpha-1-antitrypsin deficiency. Proc Natl Acad Sci USA 1994;91:9014–9018.

    Article  PubMed  CAS  Google Scholar 

  13. DeCroo, S, Kamboh MI, Ferrell RE. Population genetics of alpha-1-antitrypsin polymorphism in US whites, US blacks and African blacks. Hum Hered 1991;41:215–221.

    Article  PubMed  CAS  Google Scholar 

  14. Nukiwa T, Brantly ML, Ogushi F, Fells GA, Crystal RG. Characterization of the gene and protein of the common alpha-1-antitrypsin normal M2 allele. Am J Hum Genet 1988;43:322–330.

    PubMed  CAS  Google Scholar 

  15. Kidd VJ, Wallace RB, Itakura K, Woo SLC. Alpha-1-antitrypsin deficiency detection by direct analysis of the mutation in the gene. Nature 1983;304:230–234.

    Article  PubMed  CAS  Google Scholar 

  16. Lomas DA, Evans DL, Finch JT, Carrell RW. The mechanism of Z alpha-1-antitrypsin accumulation in the liver. Nature 1992;357:605–607.

    Article  PubMed  CAS  Google Scholar 

  17. Sifers RN, Rogers BB, Hawkins HK, Finegold MJ, Woo SLC. Elevated synthesis of human alpha 1-antitrypsin hinders secretion of murine alpha-1-antitrypsin from hepatocytes of transgenic mice. J Biol Chem 1989;264:15,696-15,700.

    Google Scholar 

  18. Loebermann H, Tokuoka R, Deisenhofer J, Huber R. Human a 1-proteinase inhibitor: crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J Mol Biol 1984;177:531–536.

    Article  PubMed  CAS  Google Scholar 

  19. Sveger T. Liver disease in alpha-1-antitrypsin deficiency detected by screening in 200,000 infants. N Engl J Med 1976;294:1316–1321.

    Article  PubMed  CAS  Google Scholar 

  20. Sveger T. Prospective study of children with alpha-1-antitrypsin deficiency: eight year old follow-up. J Pediatr 1989;104:91–94.

    Google Scholar 

  21. Moroz SP, Cutz E, Cox DW, Sass-Kortsak A. Liver disease associated with alpha-1-antitrypsin deficiency in childhood. J Pediatr 1976;88:19–25.

    Article  PubMed  CAS  Google Scholar 

  22. Clark P, Breit SN, Dawkins RL, Penny R. Genetic study of a family with two members with Weber-Christian disease (panniculitis) and alpha-1-antitrypsin deficiency. Am J Med Genet 1982; 13:57–62.

    Article  PubMed  CAS  Google Scholar 

  23. Fortin PR, Fraser RS, Watts CS, Esdaile JM. Alpha-1 antitrypsin deficiency and systemic necrotizing vasculitis. J Rheum 1991;18:1613–1616.

    PubMed  CAS  Google Scholar 

  24. Lewis JH, Iammarino RM, Spero JA, Hasiba U. Pittsburgh: an alpha-1-antitrypsin variant causing hemorrhagic disease. Blood 1978;51:129–137.

    PubMed  CAS  Google Scholar 

  25. Owen MC, Brennan SO, Lewis JH, Carrell RW. Mutation of antitrypsin to antithrombin: alpha-1-antitrypsin Pittsburgh (358 met-to-arg), a fatal bleeding disorder. New Engl J Med 1983;309:694–698.

    Article  PubMed  CAS  Google Scholar 

  26. Moroz SP, et al. Membranoproliferative glomerulonephritis in childhood cirrhosis associated with alpha-1-antitrypsin deficiency. Pediatrics 1976;88:19–25.

    Article  CAS  Google Scholar 

  27. Wewers MD, Casolaro A, Sellers S, et al. Replacement therapy for alpha-1-antitrypsin deficiency associated with emphysema. N Engl J Med 1987;316:1055–1062.

    Article  PubMed  CAS  Google Scholar 

  28. Pittschieler K. Heterozygotes and liver involvement. Acta Paediatr 1994;393:21S–23S.

    Article  Google Scholar 

  29. Perlmutter DH. Clinical manifestations of alpha-1-antitrypsin deficiency. Gastroenterology Clin N Am 1995;24:27–43.

    CAS  Google Scholar 

  30. Garver RI Jr, Chytil A, Courtney M, Crystal RG. Clonal gene therapy: transplanted mouse fibroblast clones express human alpha-1-antitrypsin gene in vivo. Science 1987;237:762–764.

    Article  PubMed  CAS  Google Scholar 

  31. Kay MA, Baley P, Rothenberg S, et al. Expression of human alpha-1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes. Proc Natl Acad Sci USA 1992;89:89–93.

    Article  PubMed  CAS  Google Scholar 

  32. Lemarchand P, Jaffe HA, Danel C, et al. Adenovirus-mediated transfer of a recombinant human alpha-1-antitrypsin cDNA to human endothelial cells. Proc Natl Acad Sci USA 1992;89:6482–6486.

    Article  PubMed  CAS  Google Scholar 

  33. Brantly M, Courtney M, Crystal RG. Repair of the secretion defect in the Z form of alpha-1-antitrypsin by addition of a second mutation. Science 1988;242:1700–1702.

    Article  PubMed  CAS  Google Scholar 

  34. Ozaki I, Duan L, Liu SL, Pomerantz RJ, Zern MA. Application of ribozymes for gene therapy of liver disease in a 1-antitrypsin deficiency. Molecular diagnosis and gene therapy. Kluwar Academic Publishers, Dordrecht, Netherlands, 1996, pp. 106–115.

    Google Scholar 

  35. Ibarguen E, Gross CR, Savik SK, Sharp HL. Liver disease in alpha-1-antitrypsin deficiency: prognostic indicators. J Pediatr 1990; 117:864–870.

    Article  PubMed  CAS  Google Scholar 

  36. Eriksson S, Carlson J, Velez R. Risk of cirrhosis and primary liver cancer in alpha-1-antitrypsin deficiency. N Engl J Med 1986;314:736–739.

    Article  PubMed  CAS  Google Scholar 

  37. Campra JL, Craig JP, Peters RL, Reynolds TB. Cirrhosis associated with partial deficiency of alpha-1-antitrypsin in adults. Ann Intern Med 1973;78:233–238.

    PubMed  CAS  Google Scholar 

  38. Sveger T. Screening for alpha-1-antitrypsin deficiency. Acta Paediatr 1994;393:18S–20S.

    Article  Google Scholar 

  39. Udall JN Jr, Dixon M, Newman AP, Wright JA, James B, Bloch KJ. Liver disease in alpha 1-antitrypsin deficiency. A retrospective analysis of the influence of early breast-vs bottle-feeding. JAMA 1985;253:2679–2682.

    Article  PubMed  Google Scholar 

  40. Psacharopoulos HT, Mowat AP, Cook PJ, Carlile PA, Portmann B, Rodeck CH. Outcome of liver disease associated with alpha-1-antitrypsin deficiency (PiZ). Implications for genetic counseling and antenatal diagnosis. Arch Dis Child 1983;58:882–887.

    Article  PubMed  CAS  Google Scholar 

  41. Esquivel CO, Marino IR, Fioravanti V, Van Thiel DH. Liver transplantation for metabolic disease of the liver. Gastroenterol Clin North Am 1988; 17:167–175.

    PubMed  CAS  Google Scholar 

  42. Burdelski M. Diagnostic, preventive, medical and surgical management of alpha-1-antitrypsin deficiency in childhood. Acta Paediatr 1994;393:33S–36S.

    Article  Google Scholar 

Suggested Reading

  1. Alagille D. Alpha-1-Antitrypsin deficiency. Hepatology 1984;4:11S–14S.

    Article  PubMed  CAS  Google Scholar 

  2. Deutsch J, Becker H, Aubock L. Histopathological features of liver disease in alpha-1-antitrypsin deficiency. Acta Paediatr 1994;393:8S–12S.

    Article  Google Scholar 

  3. Eriksson SG. Liver disease in alpha 1-antitrypsin deficiency. Aspects of incidence and prognosis. Scand J Gastroenterol 1985;20:907–911.

    Article  PubMed  CAS  Google Scholar 

  4. Massi G, Chiarelli C. Alpha-1-antitrypsin: molecular system and the Pi system. Acta Paediatr 1994;393:1S–4S.

    Article  Google Scholar 

  5. Poley JR. Malignant liver disease in alpha-1-antitrypsin deficiency. Acta Paediatr 1994;393:27S–32S.

    Article  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Herrine, S.K., Zern, M.A. (1998). Alpha-1-Antitrypsin Deficiency. In: Wu, G.Y., Israel, J. (eds) Diseases of the Liver and Bile Ducts. Current Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-1808-1_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-1808-1_20

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4612-7293-9

  • Online ISBN: 978-1-4612-1808-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics